David G Coffey

17PUBLICATIONS
96CO-AUTHORS
Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Immunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Sep 18, 2026
RHOA Deletion Downregulates CD19 and Promotes Dysfunctional Immune Microenvironments in CAR-T Resistant Large B-cell Lymphomas.

|Jul 28, 2026
Navigating the Therapeutic Landscape of Multiple Myeloma: Immunotherapy, Microenvironment, and Resistance.

|Oct 27, 2025
Machine learning reveals distinct T-cell receptor clusters in plasma cell dyscrasias compared to healthy controls.

David G Coffey, Yong Zhang, Elizabeth Hill

|Jul 01, 2025
Tocilizumab prophylaxis for patients with multiple myeloma treated with bispecific antibodies.

Andrew Kowalski, Jill Lykon, Benjamin Diamond

|Apr 08, 2025
A phase 1 trial of fully human BCMA CAR-T therapy for relapsed/refractory multiple myeloma with 5-year follow-up.

Sherilyn A Tuazon, Andrew J Portuguese, Margot J Pont

|Oct 07, 2024
Single-cell analysis of the multiple myeloma microenvironment after γ-secretase inhibition and CAR T-cell therapy.

David G Coffey, Pinar Ataca Atilla, Erden Atilla

Pageof 3

Frequent Collaborators

6 joint publications

Ola Landgren

5 joint publications

Francesco Maura

4 joint publications

Benjamin T Diamond

3 joint publications

Damian J Green